{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:25:51Z","timestamp":1786721151325,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","award":["10947"],"award-info":[{"award-number":["10947"]}],"id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.141874","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T17:38:59Z","timestamp":1741455539000},"page":"141874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P2","title":["Designing pegylated dextran sheathed doxorubicin loaded iron nanoparticles against premenopausal breast cancer"],"prefix":"10.1016","volume":"307","author":[{"given":"Amrendra","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti Abhishek","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafquat","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shourya","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Kothuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srishty","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobhit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav N.","family":"Mugale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Chourasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.141874_bb0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","article-title":"Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis","volume":"5","author":"Feng","year":"2018","journal-title":"Genes Dis."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0010","doi-asserted-by":"crossref","DOI":"10.1177\/11769351231172589","article-title":"Prevalence of Iron deficiency and its association with breast Cancer in premenopausal compared to postmenopausal women in Al Ahsa, Saudi Arabia","volume":"22","author":"Al Khamees","year":"2023","journal-title":"Cancer Informat."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0015","first-page":"1895","article-title":"The role of iron homeostasis and iron-mediated ROS in cancer","volume":"11","author":"Ying","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1471-2407-13-307","article-title":"A link between premenopausal iron deficiency and breast cancer malignancy","volume":"13","author":"Jian","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2217\/fon.11.24","article-title":"Management of anemia in cancer patients","volume":"7","author":"Calabrich","year":"2011","journal-title":"Future Oncol."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0030","series-title":"Small Molecules in Targeted cancer Therapy: Advances, Challenges, and Future Perspectives","first-page":"6","author":"Zhong","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0035","article-title":"Doxorubicin-induced cardiotoxicity and risk factors","volume":"50","author":"Belger","year":"2024","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25122874","article-title":"Magnetic hyperthermia for Cancer treatment: Main parameters affecting the outcome of in vitro and in vivo studies","volume":"25","author":"Vilas-Boas","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0045","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fphar.2017.00992","article-title":"The role of Ferroptosis in Cancer development and treatment response","volume":"8","author":"Lu","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081157","article-title":"Advantages and disadvantages of using magnetic nanoparticles for the treatment of complicated ocular disorders","volume":"13","author":"Schneider-Futschik","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/17425247.2023.2166484","article-title":"Magnetic nanoparticles: multifunctional tool for cancer therapy","volume":"20","author":"Khizar","year":"2023","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0060","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4155\/fmc.10.5","article-title":"Nanomedicine strategies for molecular targets with MRI and optical imaging","volume":"2","author":"Pan","year":"2010","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071872","article-title":"Recent advances in the development of drug delivery applications of magnetic nanomaterials","volume":"15","author":"Pusta","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901058","article-title":"Magnetic nanoparticles in Cancer therapy and diagnosis","volume":"9","author":"Farzin","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/mp0500014","article-title":"Iron oxide nanoparticles for sustained delivery of anticancer agents","volume":"2","author":"Jain","year":"2005","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/smll.200600009","article-title":"Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery","volume":"2","author":"Kohler","year":"2006","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0085","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s11095-010-0260-1","article-title":"PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications","volume":"27","author":"Yallapu","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0090","series-title":"International Journal of Pharmaceutics","first-page":"16","article-title":"A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting","author":"Gautier","year":"2012"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0095","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1021\/nl201978c","article-title":"Self-assembly of phospholipid\u2013PEG coating on nanoparticles through dual solvent exchange","volume":"11","author":"Tong","year":"2011","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0100","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1021\/acsnano.8b08702","article-title":"Dextran-coated Iron oxide nanoparticles as biomimetic catalysts for localized and pH-activated biofilm disruption","volume":"13","author":"Naha","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano10081441","article-title":"Surface modification of iron oxide-based magnetic nanoparticles for cerebral theranostics: application and prospection","volume":"10","author":"Wu","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1039\/B918416C","article-title":"Complete separation of magnetic nanoparticles via chemical cleavage of dextran by ethylenediamine for intracellular uptake","volume":"20","author":"Lin","year":"2010","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0115","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1039\/c0jm00994f","article-title":"Magnetic nanoparticles: biomedical applications and challenges","volume":"20","author":"Tran","year":"2010","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0120","article-title":"Magnetic nanosystem a tool for targeted delivery and diagnostic application: current challenges and recent advancement","volume":"7","author":"Rarokar","year":"2024","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0125","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5567","article-title":"Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (review)","volume":"63","author":"Tian","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0130","first-page":"66","article-title":"Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging","volume":"32","author":"Ko","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0140","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/1061186X.2015.1052072","article-title":"Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine","volume":"23","author":"Mattheolabakis","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0145","article-title":"CD44-targeted Nanocarrier for Cancer therapy","volume":"12","author":"Kesharwani","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0150","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.biomaterials.2013.01.078","article-title":"The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer","volume":"34","author":"Zhou","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0155","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1021\/acs.molpharmaceut.9b00177","article-title":"Induction of mitochondrial cell death and reversal of anticancer drug resistance via Nanocarriers composed of a Triphenylphosphonium derivative of Tocopheryl polyethylene glycol succinate","volume":"16","author":"Singh","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-7439(98)00065-3","article-title":"Experimental design and optimization","volume":"42","author":"Lundstedt","year":"1998","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep26895","article-title":"Formulation optimization of docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity","volume":"6","author":"Valicherla","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.125740","article-title":"Co-precipitation synthesis of stable iron oxide nanoparticles with NaOH: new insights and continuous production via flow chemistry","volume":"399","author":"Besenhard","year":"2020","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0175","doi-asserted-by":"crossref","first-page":"71705","DOI":"10.1039\/C6RA06007B","article-title":"Macrophage-targeted chitosan anchored PLGA nanoparticles bearing doxorubicin and amphotericin B against visceral leishmaniasis","volume":"6","author":"Singh","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0180","article-title":"Development of asolectin-based liposomal formulation for controlled and targeted delivery of erlotinib as a model drug for EGFR monotherapy","volume":"1\u201310","author":"Pardeshi","year":"2022","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12645-023-00176-9","article-title":"Doxorubicin-loaded polymeric nanoparticles containing ketoester-based block and cholesterol moiety as specific vehicles to fight estrogen-dependent breast cancer","volume":"14","author":"Misiak","year":"2023","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ph13090235","article-title":"Combination therapy with doxorubicin-loaded reduced albumin nanoparticles and focused ultrasound in mouse breast Cancer xenografts","volume":"13","author":"Kim","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0195","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2022.5095","article-title":"Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors","volume":"49","author":"Sawasdee","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212438","article-title":"Doxorubicin-resistant TNBC cells exhibit rapid growth with Cancer stem cell-like properties and EMT phenotype, which can be transferred to parental cells through autocrine signaling","volume":"22","author":"Paramanantham","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061758","article-title":"Synthesis, characterization, and in vitro cytotoxicity evaluation of doxorubicin-loaded magnetite nanoparticles on triple-negative breast Cancer cell lines","volume":"15","author":"Markhulia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0210","doi-asserted-by":"crossref","first-page":"29228","DOI":"10.1039\/D0RA03467C","article-title":"Novel pH-sensitive and biodegradable micelles for the combined delivery of doxorubicin and conferone to induce apoptosis in MDA-MB-231 breast cancer cell line","volume":"10","author":"Rahmani","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0215","doi-asserted-by":"crossref","first-page":"22214","DOI":"10.1021\/acsomega.9b03594","article-title":"Folic acid-functionalized, condensed magnetic nanoparticles for targeted delivery of doxorubicin to tumor Cancer cells overexpressing the folate receptor","volume":"4","author":"Angelopoulou","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0220","doi-asserted-by":"crossref","first-page":"17573","DOI":"10.1021\/acsami.5b05038","article-title":"Self-assembled nanoparticles based on amphiphilic anticancer drug-phospholipid complex for targeted drug delivery and intracellular dual-controlled release","volume":"7","author":"Li","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/jof7030188","article-title":"Induction of apoptosis in MDA-MB-231 cells treated with the methanol extract of lichen Physconia hokkaidensis","volume":"7","author":"Noh","year":"2021","journal-title":"J. Fungi"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0230","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/nnm-2022-0268","article-title":"Enhanced apoptosis and mitochondrial cell death by paclitaxel-loaded TPP-TPGS1000-functionalized Nanoemulsion","volume":"18","author":"Yadav","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0235","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.2147\/IJN.S163858","article-title":"Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes","volume":"13","author":"Shi","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0240","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/nnm-2022-0268","article-title":"Enhanced apoptosis and mitochondrial cell death by paclitaxel-loaded TPP-TPGS(1000)-functionalized nanoemulsion","volume":"18","author":"Yadav","year":"2023","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ph15091104","article-title":"Plasma pharmacokinetics and tissue distribution of doxorubicin in rats following treatment with Astragali Radix","volume":"15","author":"Huang","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0250","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00434396","article-title":"Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in nude mice","volume":"5","author":"Johansen","year":"1981","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0255","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1021\/acs.molpharmaceut.7b00310","article-title":"Click Biotinylation of PLGA template for biotin receptor oriented delivery of doxorubicin hydrochloride in 4T1 cell-induced breast Cancer","volume":"14","author":"Singh","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0260","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/0975-7406.72138","article-title":"Evaluation of immunomodulatory potential of ethanolic extract of Roscoea procera rhizomes in mice","volume":"2","author":"Sahu","year":"2010","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jconrel.2014.10.010","article-title":"Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response","volume":"196","author":"Pawar","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0270","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.freeradbiomed.2010.12.028","article-title":"Effects of iron deficiency and iron overload on angiogenesis and oxidative stress\u2014a potential dual role for iron in breast cancer","volume":"50","author":"Jian","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087286","article-title":"Hyaluronic acid-based Nanosystems for CD44 mediated anti-inflammatory and Antinociceptive activity","volume":"24","author":"Salathia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141874_bb0280","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025024250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025024250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:38:38Z","timestamp":1782902318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025024250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":56,"alternative-id":["S0141813025024250"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141874","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing pegylated dextran sheathed doxorubicin loaded iron nanoparticles against premenopausal breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"141874"}}